Find your next paid study

Medical College of WisconsinNCT03375619

~$10 – $750

Actual pay is set by the research site.

Phase 2

A Multicenter, Open-label, Phase 2 Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC (Uncommon EGFR Mutations Only)

The main objective of the study will be to evaluate the efficacy of sutetinib maleate capsules in participants with locally advanced or metastatic non-small ce…

Non-small Cell Lung Cancer

~$75 – $3,000

Actual pay is set by the research site.

Teligene USNCT06010329

NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more

A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE892 as Monotherapy and Combination Therapy in Participants With MTAP-Deleted Advanced Solid Tumors

This is a multicenter clinical study to evaluate the safety, efficacy, and Pharmacokinetics (PK) of IDE892 as monotherapy and in combination with other agents …

IDEAYA BiosciencesNCT07277413

Actual pay is set by the research site.

Observational

Assessment of Fall Risks and Subject-specific Training for Fall Reduction

The target population of this project is older people with high risks of falls. About 30% community-dwelling individuals over 65 years of age fall each year an…

Fall Risk

University of Maryland, BaltimoreNCT06396650

~$10 – $750

Actual pay is set by the research site.

Metastatic Breast CancerBreast CancerBreast Cancer Stage IV+5 more

Does Ablation (Cryoablation or Histotripsy) Boost Immune Response Improving the Benefits of Pembrolizumab in Patients With Metastatic or Locally Advanced Triple Negative Breast Cancer?

Participants will have a confirmed diagnosis of metastatic breast cancer and will receive pembrolizumab in combination with ablation (cryoablation or histotrip…

Memorial Sloan Kettering Cancer CenterNCT06246968

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

DISCERN: Dual Immune Strategy Versus Single Checkpoint Inhibition Efficacy Response in PDL-1 Negative Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study, known as DISCERN, is to compare two different treatments for a type of lung cancer called non-small cell lung cancer (NSCLC) that do…

Non Small Cell Lung Cancer

University of Alabama at BirminghamNCT06364917

~$75 – $2,000

Actual pay is set by the research site.

RET-altered Non Small Cell Lung CancerRET-altered Solid Tumors

Phase I/II Study of the Selective RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities

Phase 1 and 2 trial to study the safety, pharmacokinetics, and efficacy of TAS0953/HM06 in patients with advanced solid tumors with RET gene abnormalities. Pha…

Taiho Pharmaceutical Co., Ltd.NCT04683250

Actual pay is set by the research site.

Solid Tumor, AdultCarcinoma, Ovarian EpithelialFallopian Tube Neoplasms+3 more

A Phase I/Ib Study of BP1001-A (a Liposomal Grb2 Antisense Oligonucleotide) in Patients With Advanced or Recurrent Solid Tumors

This is a phase I, open-label, study of BP1001-A in participants with advanced or recurrent solid tumors. The dose escalation phase will determine the safety a…

Bio-Path Holdings, Inc.NCT04196257

Actual pay is set by the research site.

Locally Advanced Rectal CarcinomaRectal AdenocarcinomaStage II Rectal Cancer AJCC v8+7 more

Organ Preservation for Patients With Locally Advanced Rectal Adenocarcinoma: Evaluating the Efficacy of Short Course Radiation Therapy Followed by FOLFOX or CapeOX

This phase I trial investigates how well short-course radiation therapy followed by combination chemotherapy works in treating patients with stage II-III recta…

Jonsson Comprehensive Cancer CenterNCT04703101

~$150 – $3,000

Actual pay is set by the research site.

Observational

FAACTS: Feasibility/Acceptability of Attentional-Control Training in Survivors

This is a multicenter pilot randomized controlled trial, with an active control condition, of the feasibility, acceptability, and preliminary efficacy of Endea…

Pediatric CancerPediatric ALLPediatric Brain Tumor+2 more

Children's National Research InstituteNCT05528939

~$10 – $675

Actual pay is set by the research site.

Colorectal CancerGastro Esophageal Junctional CancerGastric Cancer (GC)+5 more

A Phase 1 Dose Escalation Trial to Determine the Safety, Tolerance, Maximum Tolerated Dose, and Preliminary Antineoplastic Activity of the IKS04 Regimen Targeting CA242

This study will evaluate the safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of the IKS04 Regimen and identify…

Iksuda Therapeutics Ltd.NCT07738939

Actual pay is set by the research site.

Lung Cancer (Locally Advanced or Metastatic)

A Phase IB, Single Dose, Open-Label, Dose-escalation Study to Investigate the Safety and Imaging Characteristics of Pemefolacianine for Intraoperative Molecular Imaging of Lung Cancer

The aim of this Phase 1b study is to investigate the safety and fluorescence signal of a single dose of Pemefolacianine for Injection, a novel fluorescence ima…